Charles R Schaller - Net Worth and Insider Trading
Charles R Schaller Net Worth
The estimated net worth of Charles R Schaller is at least $12,088 dollars as of 2024-04-26. Charles R Schaller is the Director of Celldex Therapeutics Inc and owns about 333 shares of Celldex Therapeutics Inc (CLDX) stock worth over $12,088. Details can be seen in Charles R Schaller's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles R Schaller has not made any transactions after 2010-09-09 and currently still holds the listed stock(s).
Transaction Summary of Charles R Schaller
Charles R Schaller Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles R Schaller owns 1 companies in total, including Celldex Therapeutics Inc (CLDX) .
Click here to see the complete history of Charles R Schaller’s form 4 insider trades.
Insider Ownership Summary of Charles R Schaller
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2010-09-09 | director |
Charles R Schaller Latest Holdings Summary
Charles R Schaller currently owns a total of 1 stock. Charles R Schaller owns 333 shares of Celldex Therapeutics Inc (CLDX) as of September 9, 2010, with a value of $12,088.
Latest Holdings of Charles R Schaller
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2010-09-09 | 333 | 36.30 | 12,088 |
Holding Weightings of Charles R Schaller
Charles R Schaller Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles R Schaller has made a total of 0 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years. The most-recent trade in Celldex Therapeutics Inc is the acquisition of 333 shares on September 9, 2010, which cost Charles R Schaller around $17,250.
Insider Trading History of Charles R Schaller
- 1
Charles R Schaller Trading Performance
GuruFocus tracks the stock performance after each of Charles R Schaller's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles R Schaller is 15.58%. GuruFocus also compares Charles R Schaller's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles R Schaller within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles R Schaller's insider trading performs compared to the benchmark.
Performance of Charles R Schaller
Average Return
-17.33%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.03 | 15.58 | 29.78 | -17.33 | -9.81 | 19.23 |
| Relative Return to S&P 500(%) | -3.89 | 15.34 | 24.37 | -28.86 | -20.13 | 8.5 |
Charles R Schaller Ownership Network
Ownership Network List of Charles R Schaller
Ownership Network Relation of Charles R Schaller
Charles R Schaller Owned Company Details
What does Celldex Therapeutics Inc do?
Who are the key executives at Celldex Therapeutics Inc?
Charles R Schaller is the director of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include Sen. VP & Ch Scientific Off. Tibor Keler , SVP of Corp. Affairs & Admin. Sarah Cavanaugh , and SVP & Chief Medical Officer Diane C. Young .
Celldex Therapeutics Inc (CLDX) Insider Trades Summary
Over the past 18 months, Charles R Schaller made no insider transaction in Celldex Therapeutics Inc (CLDX). Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 16,860 shares made by Tibor Keler ,
In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,860 shares of Celldex Therapeutics Inc (CLDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,860 shares.
Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Celldex Therapeutics Inc Insider Transactions
Charles R Schaller Mailing Address
Above is the net worth, insider trading, and ownership report for Charles R Schaller. Currently GuruFocus does not have mailing address information for Charles R Schaller.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
